As of September this year, based on Oscar Health's most recent financial report, the company's trailing twelve months EPS is $1.61. Oscar Health's earnings per share in 2025 was reported at -$1.69, marking a decline from $0.11 in 2024. Oscar Health's EPS for the quarterly period ending on Jun 30, 2026 came in at $1.2.
The yearly earnings per share during 2025 was -$1.69, a decline of 1,636.4% compared to $0.11 recorded in 2024. The quarterly earnings per share for the period ending Jun 30, 2026, was $1.2, showing a 234.8% increase compared to the same quarter last year. The trailing twelve months EPS for OSCR is $1.61 as of June 2026. Oscar Health's full-year EPS for 2024 was $0.11, a 109% rise compared to the previous year.
Oscar Health has recorded a growth in earnings per share of 234.8% in the past 12 months (YoY, quarterly).
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| PFG Principal Financial Group Inc | 15.98 | -21.4% | -34.5% | 0.9% |
| OSCR Oscar Health Inc | 18.96 | -1,636.4% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.